Get started
Live feed
·
PRReleasevia Quantisnow
ASLAN Pharmaceuticals Limited logo

ASLAN Pharmaceuticals Announces Positive Data Conclusively Establishing Proof of Concept for ASLAN004 in Atopic Dermatitis

ByQuantisnow·Wall Street's wire, on your screen.
ASLNASLAN Pharmaceuticals Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASLN (ASLAN Pharmaceuticals Limited) and more on Quantisnow.